Please find herewith the Public Announcement in relation to Open Offer to public shareholders issued by SBI Capital Markets Limited.
BLISSGVS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Anupam Rasayan India Limited has triggered a mandatory open offer for Bliss GVS Pharma Limited following a Share Purchase Agreement dated May 23, 2026. Under the SPA, the acquirer will purchase 4,58,03,024 shares (43.30% stake) from existing promoters and public shareholders at up to ₹299 per share, totaling approximately ₹1,370 crore. The open offer seeks to acquire an additional 2,77,26,848 shares representing 26% of expanded voting capital at the same price, amounting to about ₹829 crore. The combined acquisition could give Anupam Rasayan control of up to 69.51% of Bliss GVS. Existing promoters including Narsimha Shibroor Kamath and others will exit, and the current promoter group will be reclassified as public shareholders. The acquirer has confirmed it does not intend to delist the company.
Current shareholders of Bliss GVS Pharma have an opportunity to exit at ₹299 per share (premium to market). The stock may see price movement toward the offer price as the market reacts to the change in control. Anupam Rasayan India Limited, a specialty chemicals company, will gain significant presence in the pharma sector through this acquisition.